BSD Medical (Long Term Investment Oriented) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BSD Medical (Long Term Investment Oriented)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: pleonastic who wrote (82)	1/22/2013 2:12:08 PM
From: fwhco	1 Recommendation Read Replies (1) of 178

Ray, I am also optimistic about the near-term future of BSD's 2000 series machines. Based on what I see, I think it is possible for submission to the FDA this year. Consider the following: 1. Look at the brochure Dr. Sennewald has published. One of the charts shows [p.8] shows long-term survival flat line of near 50% at 48 months, approaching 5 years now for cervix cancer. P.10 shows a chart for soft tissue sarcomas ~50% survival @ ~110 months vs. 0% non-responders at 36 months. bsdmc.com 2. As an adjunct therapy, BSD's 2000/3D/MRI machines will have a lot of synergy with CLSN's Thermodox when TD is approved. What better way is there to focus heat to a tumor than an MRI guided hyperthermia device? 3. As seen in Dr. Poon's presentation about Thermodox, the BSD-500 was the heating machine used in the P-II trial for recurrent chest wall breast cancer. See p.26. From the picture, the results look stunningly good. files.shareholder.com IMO, I don't think the FDA can deny approval on the next submission.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next